Palatin Technologies (PTN)

ที่อัปเดต:
Breakout, retest, potential triple bottom


Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems.
บันทึก
สแนปชอต 33 cent limit in case of break down
biopharmabiopharmaceuticalChart PatternsTechnical IndicatorspalatinpennystockspharmaceuticalpharmaceuticalsPTNTECHtechnologyTrend Analysis

คำจำกัดสิทธิ์ความรับผิดชอบ